Unknown

Dataset Information

0

Paralog-divergent Features May Help Reduce Off-target Effects of Drugs: Hints from Glucagon Subfamily Analysis.


ABSTRACT: Side effects from targeted drugs remain a serious concern. One reason is the nonselective binding of a drug to unintended proteins such as its paralogs, which are highly homologous in sequences and have similar structures and drug-binding pockets. To identify targetable differences between paralogs, we analyzed two types (type-I and type-II) of functional divergence between two paralogs in the known target protein receptor family G-protein coupled receptors (GPCRs) at the amino acid level. Paralogous protein receptors in glucagon-like subfamily, glucagon receptor (GCGR) and glucagon-like peptide-1 receptor (GLP-1R), exhibit divergence in ligands and are clinically validated drug targets for type 2 diabetes. Our data showed that type-II amino acids were significantly enriched in the binding sites of antagonist MK-0893 to GCGR, which had a radical shift in physicochemical properties between GCGR and GLP-1R. We also examined the role of type-I amino acids between GCGR and GLP-1R. The divergent features between GCGR and GLP-1R paralogs may be helpful in their discrimination, thus enabling the identification of binding sites to reduce undesirable side effects and increase the target specificity of drugs.

SUBMITTER: Sa Z 

PROVIDER: S-EPMC5582795 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6755211 | biostudies-literature
| S-EPMC5808380 | biostudies-literature
| S-EPMC8940209 | biostudies-literature
| S-EPMC10297044 | biostudies-literature
2018-04-06 | GSE100903 | GEO
| S-EPMC4418430 | biostudies-literature
| S-EPMC7578565 | biostudies-literature
| S-EPMC9444818 | biostudies-literature
| S-EPMC4719450 | biostudies-literature
2014-08-26 | PXD001040 | Pride